chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 11.0
Sex: F
Vaccine: DTAP, HPV9
Symptoms: Pain in extremity, Vaccination site pain, Wrong product administered
Clinical narrative: Wrong Vaccine was administered to patient. Patient was due for Tdap but received DTap instead. Mother of patient advised soreness arm and tenderness around area where vaccine was administered.  She reports tenderness has gone away arm feels better.
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 51.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECIEVED VACCINE AFTE BUD
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Pulmonary embolism
Clinical narrative: ACUTE PULMONARY EMBOLISM
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 47.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 16.0
Sex: F
Vaccine: HPV9, MENB, MNQ
Symptoms: Immediate post-injection reaction, Loss of consciousness, Syncope
Clinical narrative: Patient had a syncopal event immediately after administration of the HPV, Menveo, and Bexsero vaccines.  She had brief LOC.  She was monitored in clinic and had full recovery within a few minutes.
Age: 26.0
Sex: M
Vaccine: MMR, MNQ, TDAP, VARCEL
Symptoms: Wrong product administered
Clinical narrative: Pt asked for TDAP, MMR, and Varicella and was inadvertently given Menveo, MMR, and Varicella.
Age: 17.0
Sex: M
Vaccine: MENB
Symptoms: Swelling, Urticaria
Clinical narrative: Patient developed urticarial wheals on bilateral knees and buttocks on 8/1/23 AM. He took Benadryl 50mg at 1230PM that day and again at approximately 1200AM on 8/2. After taking the BEnadyrl, the swelling of the urticarial wheals improved and they were less red and seemed to fade away. At about 530 PM the wheals re-appeared but were not as itchy unitl later that night whe patient to Benadryl again. On 8/2 he was seen in office with urticarial wheals on bilat knees, bilat buttocks and bilat elbows and forearms with fewer lesions on mid to lower back and poserior aspect of lower legs. At that time patient was instructed to take Ceterizine 10mg po QD and apply cool compresses and 1% HC cream to sites BID for up to 7d in a row. Patient was also instructed that for sever itching despite Ceterizine then he can take Benadryl 25mg for breakthrough every 6 hrs.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 12/27/2022  &  1/12/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 76.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: The use by date on the Moderna BiIvalent vaccination was 07/29/2023, no symptoms from the patient were reported.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension, Symptom recurrence
Clinical narrative: HYPOTENSION 1/23/2023 -- RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 11.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Rash
Clinical narrative: RASH ON HANDS AND FEET 2 DAYS AFTER VACCINE
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: Breakthrough case admission after 4 vaccines Moderna 2/5/21 lot# 007M20A;  Moderna 3/5/21 lot# 023M20A;  Moderna 10/31/21 lot# 939904;  MOderna 5/23/22 lot# 038A22A
Age: 71.0
Sex: M
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site rash
Clinical narrative: Redness/rash on around Shingrix injection site
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Janssen 3/28/21 Lot# 1805020;  Pfizer 12/2/21 lot# 213D21A
Age: 50.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Vaccination was administered on 7/31/23, later the vaccination was discovered to have a use by date of 07/29/2023. Patient has not reported any adverse reaction.
Age: 82.0
Sex: F
Vaccine: COVID19-2
Symptoms: Breakthrough COVID-19, SARS-CoV-2 test positive
Clinical narrative: Breakthrough case admission after 5 vaccines Pfizer 1/19/22 lot# FJ6369;  Pfizer 2/7/2 lot# FJ6369;  Pfizer 3/8/22 lot# FJ6369;  Pfizer 7/12/22 lot# FP4554;  Pfizer 11/28/22 lot# GL0446
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test positive, Vaccine breakthrough infection
Clinical narrative: Breakthrough case admission after 2 vaccines  Moderna 3/2/21 lot# 008B21A;  Moderna 4/30/21 lot# 043B21A
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Patient received vaccine after BUD
Age: 1.25
Sex: F
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, Underdose
Clinical narrative: Bivalent Moderna vaccine was ordered, but the monovalent vaccine was administered at a lower than intended dose.
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 59.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 64.0
Sex: F
Vaccine: COVID19-2
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: PATIENT GIVEN COVID VACCINE 2 WEEKS PRIOR TO TURNING 65. PATIENT MADE AWARE, NO SIDE EFFECTS EXPERIENCED.
Age: 19.0
Sex: F
Vaccine: MENB
Symptoms: Antibody test, Arthralgia, Diarrhoea, Headache, Myalgia
Clinical narrative: On 7/18/23, pt received 2nd dose of Men B (Bexsero), 3 hrs later, pt began having myalgia, arthralgia, headache and nausea.  On 7/20/23, pt developed fever T102.5F for 2-2.5 days.  On 7/21/23, pt developed nausea and diarrhea that lasted until 7/24/23.
Age: 19.0
Sex: F
Vaccine: MENB
Symptoms: Nausea, Occult blood, Polymerase chain reaction
Clinical narrative: On 7/18/23, pt received 2nd dose of Men B (Bexsero), 3 hrs later, pt began having myalgia, arthralgia, headache and nausea.  On 7/20/23, pt developed fever T102.5F for 2-2.5 days.  On 7/21/23, pt developed nausea and diarrhea that lasted until 7/24/23.
Age: 89.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Embolic stroke
Clinical narrative: ACUTE STROKE DUE TO EMBOLISM OF UNSPECIFIED ARTERY
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 28.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Patient received vaccine after BUD
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Arthralgia, Chills, Headache
Clinical narrative: Started having chills, joint pain, and headache during middle of night following vaccine
Age: 29.0
Sex: F
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: Pt was unknowingly given additional Pfizer BV. Upon review after pt was given the vaccine - pt shows Pfizer given on 03/2023. Vaccinator believed Pfizer given was a monovalent - but was unable to confirm. No adverse reactions.
Age: 28.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Angina unstable
Clinical narrative: UNSTABLE ANGINA ACUTE NON ST ELEVATION MI
Age: 32.0
Sex: M
Vaccine: COVID19-2
Symptoms: No adverse event
Clinical narrative: Pt was unknowingly given additional Pfizer BV. Upon review after pt was given the vaccine - pt shows Pfizer given on 03/2023. Vaccinator believed Pfizer given was a monovalent - but was unable to confirm. No adverse reactions.
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 85.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Patient received vaccine after BUD
Age: 3.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered, Product preparation error
Clinical narrative: Saturday 7/29/2023 the vaccination provided was not diluted. Monday morning 7/31/2023 the vial was found on a tray with less than one dose left in it, when there should have been 9 doses left. When MA who administered vaccination was asked about circumstances she reported that she thought she diluted the vaccination and threw away the dilutent. The dilutent was not found. No other patients received this vaccination on Saturday 7/29/2023 or Monday 7/31/2023.
Age: 1.42
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: A Moderna Covid booster indicated for patients aged 6-11 years was administered to this 1 year old patient.
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 69.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Hypoxia, Respiratory failure
Clinical narrative: ACUTE RESPIRATORY FAILURE ACUTE HYPERCAPNIC RESPIRATORY FAILURE CHRONIC RESPIRATORY FAILURE CHRONIC HYPERCAPNIC RESPIRATORY FAILURE ACUTE ON CHRONIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE HYPOXIA
Age: 6.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: Patient received a higher concentration than intended.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Acute respiratory failure, Chronic respiratory failure, Deep vein thrombosis, Pulmonary embolism, Respiratory failure
Clinical narrative: ACUTE DVT, UNSPECIFIED VEIN ACUTE HYPOXEMIC RESPIRATORY FAILURE ACUTE PULMONARY EMBOLISM CHRONIC HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Age: 2.0
Sex: F
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: A bivalent Moderna booster indicated for patients aged 6-11 years was inadvertently given to the patient.
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic respiratory failure, Respiratory failure
Clinical narrative: CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Age: 59.0
Sex: F
Vaccine: COVID19-2, PNC20, TDAP
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse effect to patient, however, she had received a dose of the bivalent COVID vaccine on 10/26/22 and did not require a second dose as she has no immunocompromise.
Age: 5.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: A bivalent Moderna booster indicated for patients aged 6-11 years was inadvertently given to this patient.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Rash
Clinical narrative: symptoms: full body rash no respiratory involvement
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction, Symptom recurrence
Clinical narrative: ACUTE NON ST ELEVATION MI 3/6/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Extra dose administered, No adverse event
Clinical narrative: No adverse event.  Pt. had previously received the Moderna bivalent vaccine on 12/7/22 and is not immunocompromised thus did not need to receive the second bivalent dose.
Age: 13.0
Sex: M
Vaccine: TDAP
Symptoms: Headache, Pyrexia
Clinical narrative: Severe headache, fever 104
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Abdominal pain, Alanine aminotransferase increased, Antinuclear antibody positive, Aspartate aminotransferase increased, Biopsy bone marrow
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Blood alkaline phosphatase increased, Blood bilirubin, Blood creatinine increased, Blood lactate dehydrogenase increased, Blood smear test abnormal
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Borrelia test negative, C-reactive protein, Chromaturia, Complement factor C3, Complement factor C4
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Coxiella test, Diarrhoea, Faeces discoloured, Foreign travel, Gamma-glutamyltransferase increased
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: HIV test, HIV test negative, Haemoglobin, Hepatitis A antibody, Hepatitis A antibody negative
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Hepatitis A virus test, Hepatitis B core antibody negative, Hepatitis B surface antigen negative, Hepatitis B test negative, Hepatitis C antibody negative
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Hepatitis C test negative, Hepatitis E antibody negative, Imaging procedure, Immunoglobulins normal, Influenza virus test negative
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Laboratory test, Liver function test increased, Malaise, Platelet count decreased, Procalcitonin normal
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Pyrexia, SARS-CoV-2 test negative, Serum ferritin increased, Smooth muscle antibody negative, Thrombocytopenia
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 58.0
Sex: M
Vaccine: YF
Symptoms: Typhus rickettsia test, White blood cell count increased
Clinical narrative: 58 yo male received YF vaccine (lot #UJ819AA) on 7/1/23 no other vaccines administered at that time, although on 5/18 received dose of Twinrix and Shingrix at another pharmacy.  YF vaccine was given in anticipation of an upcoming trip which has not taken place. 7/7 leaves did not leave the city no unusual exposures  7/14 starts feeling unwell and symptoms progress does not seek any medical care 7/23 returns  July 24 goes to local urgent care abdominal pain elevated LFTs referred to ER and subsequently admitted 7/25 Hospital Medical Center On admission 12 days of fever and abdominal pain noted dark urine, white stool, he did recall some diarrhea at the start of his symptoms.  On admission ALT 749 AST 290, AlK Phos 375, bili 3.8.  Elevated WBC (15) diminished Plts 110, Hgb 15.9 Based on imaging studies not felt to be cholecystitis.  Acute hepatitis testing negative for HAV, HBV, HCV, hep E sent out to commercial lab pending. No respiratory sx, mildly elevated create during the hospitalization that resolved.  No bleeding issues normal PT by report.  Reportedly had a bone marrow bx but no liver bx results pending Additional labs Heme WBC 15.9, Plt 118   Porcalcitonin WNL SARS-CoV-2 influenza neg Discharged 8/1 ALT down to 374, AST 204, Alk phos 241, GGT 254patient reports still feels unwell.   PMH  HTN, no hx of immune compromise or thyroid problems No prior YF vaccine
Age: 13.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECIVED VACCINE AFTER BUD.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 53.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 21.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 37.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 8.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 1.33
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: A bivalent Moderna booster indicated for patients aged 6-11 years was inadvertently administered to this patient.
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Chills, Hyperhidrosis, Hypotension, Nausea, Pain
Clinical narrative: nauseous, faint, chills, body aches, diaphoretic, hypotensive, tachycardic - 2 hrs after vaccine given epi 0.3mg given with good response
Age: 17.0
Sex: F
Vaccine: MENB
Symptoms: Syncope, Tachycardia, White blood cell count increased
Clinical narrative: nauseous, faint, chills, body aches, diaphoretic, hypotensive, tachycardic - 2 hrs after vaccine given epi 0.3mg given with good response
Age: 37.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 57.0
Sex: M
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome
Clinical narrative: ADULT OBSTRUCTIVE SLEEP APNEA, SEVERE
Age: 3.0
Sex: M
Vaccine: COVID19-2
Symptoms: Incorrect dose administered
Clinical narrative: A bivalent Moderna booster indicated for patients aged 6-11 years was inadvertently given to the patient.
Age: 36.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, Exposure during pregnancy, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.  12/12/2023
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia
Clinical narrative: HYPOXEMIA
Age: 84.0
Sex: F
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid-19 Infection
Age: 76.0
Sex: F
Vaccine: COVID19
Symptoms: Complication of pregnancy, Epilepsy
Clinical narrative: EPILEPSY IN PREGNANCY, UNSPECIFIED TRIMESTER
Age: 40.0
Sex: M
Vaccine: SMALLMNK
Symptoms: Incorrect route of product administration
Clinical narrative: Immunization given IM, not Subcutaneous
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 42.0
Sex: M
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: HYPOTENSION
Age: 16.0
Sex: M
Vaccine: MNQ
Symptoms: Extra dose administered, No adverse event, Wrong product administered
Clinical narrative: Patient was given an extra dose of Menquadfi. Pt was originally scheduled to receive Bexsero second dose. Pt completed their series with Menquadfi. No reaction after vaccination and followed up with pt's parent and states that they are good. Spoke with vaccine manufacturer and states that there is no harm to patient in receiving an extra dose.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Delivery, Live birth, Obstructive sleep apnoea syndrome
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 3/29/2023 MATERNAL DELIVERY OUTCOME, SINGLETON BIRTH, LIVEBORN
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Acute myocardial infarction
Clinical narrative: ACUTE NON ST ELEVATION MI
Age: 23.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 21.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 39.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Arterial occlusive disease, Cerebrovascular accident, Lacunar stroke, Symptom recurrence
Clinical narrative: ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY ACUTE STROKE DUE TO OCCLUSION OF UNSPECIFIED ARTERY 2/9/2023  --  RECURRENCE OF HOSPITALIZATION WITH SAME SYMPTOMS
Age: 63.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site swelling, Injection site warmth, Rash
Clinical narrative: rash on arms/hands/legs and some swelling with warmth at administration site (no swelling of tongue or throat)
Age: 37.0
Sex: F
Vaccine: VARCEL
Symptoms: Erythema, Pruritus
Clinical narrative: Reported 08/02/2023, red, mildly itchy, patches appearing 72 hours post varicella vaccination.  Continued to have itchiness with some red patches observed over her body.
Age: 20.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19
Clinical narrative: Breakthrough Covid- 19 Infection
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 19.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered, Exposure during pregnancy, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination. Due date 12/11/2023
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 74.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 20.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 30.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 59.0
Sex: M
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 34.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 12.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Arthralgia
Clinical narrative: The mother of the patient called to let the us know that her daughter's left leg above her knee started hurting once she got home shortly after getting her shots.  The patient was not having any chest pain, was not having any shortness of breath and was not having any difficulty breathing at the time of my call.  The patient's pediatrician is Dr.  I advised the mother of the patient to consult with the pediatrician.  I advised the mother to take the patient to the ER if new s&s develop and to also call the pediatrician.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Chronic obstructive pulmonary disease, Hypotension
Clinical narrative: HYPOTENSION 4/17/2023 COPD (CHRONIC OBSTRUCTIVE PULMONARY DISEASE)
Age: 18.0
Sex: M
Vaccine: MMR
Symptoms: Expired product administered
Clinical narrative: I asked a fellow MA for some help locating a vaccine and they handed it to me I didn't think to check the expiration because they handed it to me and I though they checked it come to find out they didn't and the person who verified me didn't check the expiration date either because they thought I did.
Age: 56.0
Sex: M
Vaccine: COVID19
Symptoms: Cerebrovascular accident, Transient ischaemic attack
Clinical narrative: TRANSIENT CEREBRAL ISCHEMIA 2/3/2023 TRANSIENT CEREBRAL ISCHEMIA ACUTE STROKE, UNSPECIFIED TYPE AND ARTERY 2/3/2023 TRANSIENT CEREBRAL ISCHEMIA
Age: 43.0
Sex: F
Vaccine: COVID19-2
Symptoms: Expired product administered, No adverse event
Clinical narrative: Covid vaccine was administered to patient past BUD date and therefore was not valid. Patient did not have any adverse event post vaccination.
Age: 70.0
Sex: F
Vaccine: COVID19
Symptoms: Hypotension
Clinical narrative: I95.9 HYPOTENSION 5/2/2023 HX OF SUBSTANCE USE DISORDER
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Hypoaesthesia, Nausea, Neuralgia, Pain, Paraesthesia
Clinical narrative: Nausea, Vomiting, body aches which started in the evening after vaccination. Then later in the evening she developed numbness and tingling in the toes. Patient had previously dealt with several months of numbness, tingling, and neuropathic pain in her left leg and left arm which eventually improved after a course of steroids and had been resolved for several months prior to vaccine administration
Age: 17.0
Sex: F
Vaccine: MENB, MNQ
Symptoms: Vomiting
Clinical narrative: Nausea, Vomiting, body aches which started in the evening after vaccination. Then later in the evening she developed numbness and tingling in the toes. Patient had previously dealt with several months of numbness, tingling, and neuropathic pain in her left leg and left arm which eventually improved after a course of steroids and had been resolved for several months prior to vaccine administration
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Obstructive sleep apnoea syndrome, Pelvic pain
Clinical narrative: G47.33 OBSTRUCTIVE SLEEP APNEA 11/11/2022 ACUTE FEMALE PELVIC PAIN
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 57.0
Sex: F
Vaccine: COVID19
Symptoms: Angina pectoris
Clinical narrative: I20.9 ANGINA, UNSPECIFIED 3/24/2023 ANGINA, UNSPECIFIED
Age: 2.0
Sex: F
Vaccine: COVID19-2, DTAP
Symptoms: Wrong patient received product
Clinical narrative: VACCINES INADVERTENTLY ADMINISTERED TO THIS PATIENT WHEN IT SHOULD HAVE BEEN GIVEN TO SIBLING
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Abdominal distension, Computerised tomogram, Glycosylated haemoglobin increased, Joint swelling, Ultrasound scan
Clinical narrative: Entire core of body and abdomen area became swollen for months. Swelling remains in right shoulder blade are and right lower back/hip.
Age: 68.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: X-ray
Clinical narrative: Entire core of body and abdomen area became swollen for months. Swelling remains in right shoulder blade are and right lower back/hip.
Age: 68.0
Sex: F
Vaccine: COVID19
Symptoms: Hypoxia, Major depression
Clinical narrative: R09.02 HYPOXIA 4/30/2023 MAJOR DEPRESSIVE DISORDER, SINGLE EPISODE, MODERATE
Age: 61.0
Sex: M
Vaccine: COVID19
Symptoms: Acute respiratory failure, End stage renal disease
Clinical narrative: ACUTE RESPIRATORY FAILURE 4/17/2023 ESRD (END STAGE RENAL DISEASE)
Age: 20.0
Sex: F
Vaccine: MENB
Symptoms: Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: The day after Bexsero imm #1 reported hard knot at and around site of injection, felt like injection stayed in area and did not disperse, swelling, warm to touch, painful
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 30.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 30.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect product formulation administered, No adverse event, Wrong product administered
Clinical narrative: on 4/19/23 pt received mono-valent Pfizer instead of bi-valent. no adverse rxn, just received incorrect vaccine
Age: 49.0
Sex: M
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 11.0
Sex: F
Vaccine: MENB, MNQ, TDAP
Symptoms: No adverse event, Wrong product administered
Clinical narrative: Provider and Mom were both notified of Men B being given inadvertently. Patient had no side effects or reactions at time of call. Mom was informed to let us know if anything appears.
Age: 16.0
Sex: F
Vaccine: MENB
Symptoms: Chills, Headache, Mobility decreased, Nausea, Peripheral swelling
Clinical narrative: Mother called this nurse today and stated that about 1 hour after the patient got the vaccine she started having chills, headache, and nausea. This morning she woke up with a very swollen arm and now mother states that the patient can hardly move her arm. Advised to get seen as soon as possible.
Age: 12.0
Sex: F
Vaccine: MENB
Symptoms: Wrong product administered
Clinical narrative: 12 year old female , received a dose of Bexsero instead of MCV4
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 49.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 42.0
Sex: F
Vaccine: COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 65.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: PATIENT RECEIVED VACCINE AFTER BUD.
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Expired product administered
Clinical narrative: Patient received vaccine after BUD
Age: 35.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Product storage error
Clinical narrative: Patient received vaccine after BUD
Sex: F
Vaccine: COVID19-2
Symptoms: Dementia Alzheimer's type
Clinical narrative: she has Alzheimer's and dementia; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 24-Jul-2023 and was forwarded to Moderna on 26-Jul-2023.    This spontaneous case was reported by a consumer and describes the occurrence of DEMENTIA ALZHEIMER'S TYPE (she has Alzheimer's and dementia) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) for COVID-19 prophylaxis.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On an unknown date, the patient experienced DEMENTIA ALZHEIMER'S TYPE (she has Alzheimer's and dementia) (seriousness criterion medically significant). At the time of the report, DEMENTIA ALZHEIMER'S TYPE (she has Alzheimer's and dementia) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered DEMENTIA ALZHEIMER'S TYPE (she has Alzheimer's and dementia) to be related.    Reporter had to watch the demise of his grandmother. Patient had Alzheimer's and dementia, and she never had that in her life. Reporter told her that she should not get the Covid-shot. And now the doctor told that, wish they should never gave it to  because your actual issue that you're had was vaccine related Dementia. Concomitant medications were not reported.  No treatment information was provided by the reporter. Company comment: This spontaneous case concerns a female patient of an unknown age, with no medical history reported, who experienced the unexpected and serious (medically significant) event of DEMENTIA ALZHEIMER'S TYPE after vaccination with an unspecified dose of mRNA-1273.222 vaccine. The vaccination date and the onset of the event were not reported; hence, latency to vaccination could not be properly assessed. No details of other doses were provided. No further clinical information was available for medical review. The benefit-risk relationship of mRNA-1273.222 vaccine is not affected by this report.   This case was linked to US-MODERNATX, INC.-MOD-2023-734472, US-MODERNATX, INC.-MOD-2023-734863, US-MODERNATX, INC.-MOD-2023-734864 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-734472:Invalid case (Patient 1 - MOD-2023-734472) & Grandmother case (MOD-2023-734538 - Patient 2) US-MODERNATX, INC.-MOD-2023-734864:Grandmother case (MOD-2023-734538 - Patient 2)  & Patient 4 (Fatal - MOD-2023-734864) US-MODERNATX, INC.-MOD-2023-734863:Grandmother's case (MOD-2023-734538) & MOD-2023-734863- Patient 3 (Fatal outcome)